Flow cytometric analysis of monocytic MDSCs (CD14 + HLADR- CD11b + CD33 + ) revealed a slight increase in PD patients compared to controls with a trending increase in the later stages of disease (Fig. 1d). This evidence concerns the gene CD33 and Parkinson disease.